A flight carrying the primary lot of Sputnik V vaccines from Russia landed in Hyderabad, Telangana on Saturday. Last month, the Drug Controller General (DCGI) had issued permission for Dr. Reddy’s Laboratories to import the Russian vaccine to India for emergency use.
The rollout of the Russian vaccine is anticipated to enhance India’s third part of the vaccination drive which commenced as we speak amid a report rise in COVID-19 instances. India for the primary time has reported greater than 4 lakh new COVID-19 instances in the final 24 hours.
A complete of 4,01,993 contemporary COVID-19 instances had been recorded in the final 24 hours taking the cumulative depend of the instances to 1,91,64,969, the Union Health Ministry reported on Saturday.
Sputnik V is the third vaccine India has given the go-ahead to after Covishield, developed by Oxford University and AstraZeneca, and Covaxin, the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
Earlier, the Indian envoy to Russia Bala Venkatesh Varma had stated that India expects between 150,000 to 200,000 ready-made vaccines to be out there in a short time in the early half of May. Diplomatic sources had instructed ANI that India will get a substantive quantity of vaccines in the primary tranche and the provision will proceed in installments. India is anticipating 5 million vials of Sputnik vaccines by the subsequent month.
In different information, with 3,523 folks succumbing to the an infection in the final 24 hours, the dying toll has mounted to 2,11,853 in India. Currently, there are 32,68,710 lively instances of COVID-19 in the nation. India additionally witnessed as many as 2,99,988 recoveries in the final 24 hours taking the cumulative recoveries to 1,56,84,406.
(Inputs from ANI)